MBXBF - Microbix Schedules Release of Results for Q1 Fiscal 2024 | Benzinga
MISSISSAUGA, Ontario, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX:MBX, OTCQX:MBXBF, Microbix®)), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its first quarter of fiscal 2024 ended December 31, 2023 prior to the start of trading on February 14, 2024. Furthermore, at 10:00 AM ET on that day, Microbix intends to hold a webinar discussion of Q1 2024 results with its CEO, CFO, and COO.
Investor and shareholders can participate in the webinar, hosted by Adelaide Capital, by registering at: https://us02web.zoom.us/webinar/register/WN_N3yHVFwcQNq0bA3MeJHPSg
It will also be live-streamed to YouTube at: https://www.youtube.com/channel/UC7Jpt_DWjF1qSCzfKlpLMWw.
Telephone participation in the webinar can be arranged by contacting Microbix or Adelaide capital at the contact numbers provided at the end of this news release.
A replay of the webinar will also be made available on Adelaide Capital's YouTube channel.
About Microbix Biosystems Inc.
Microbix Biosystems Inc. creates proprietary biological products for human health, with over 100 skilled employees and annualized sales targeting C$ 2.0 million per month. It makes a wide range of critical ingredients and devices for ...